re: Remdesivir trials:
https://www.cnn.com/2020/02/26/us/coronavirus-us-american-treatment-trial/index.html
Participants in the US treatment group will receive 200 milligrams of remdesivir intravenously when they’re enrolled in the study. They will receive another 100 milligrams while they are hospitalized for up to 10 days total. A placebo group will receive a solution that resembles remdesivir but contains only inactive ingredients, the NIH said.
Are these infected/uninfected people?
Let’s hope the results are such that the study is cancelled and the placebo people become the treated people. That happens sometimes.